Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

01.09.2019 | editorial

Screening and prophylaxis of cancer

verfasst von: Holger Rumpold, MD

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Auszug

Cancer is the second most common cause of death in developed countries, preceded only by heart diseases. Due to demographic changes, the number of cancer patients is rising and will increase to an estimated 15 million people in the United States by 2020, for example. This increase is complemented by the recent progress in treatment of cancer. This has led to a significant increase of cancer-related survival rates across all entities. The success in the fight against cancer is further augmented by screening programs enabling the detection of cancer in early stages, when cure is more likely to be reached than in later stages. …
Vorheriger Artikel Immunosuppression and its complications
Nächster Artikel Post San Antonio
Literatur
1.
Miller SM, et al. Primary prevention, aging, and cancer: overview and future perspectives. Cancer. 2008;113:3484–92.CrossRef
2.
3.
4.
Metadaten
Titel
Screening and prophylaxis of cancer
verfasst von
Holger Rumpold, MD
Publikationsdatum
01.09.2019
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 3/2019
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-019-00526-7

Weitere Artikel der Ausgabe 3/2019

Post San Antonio: immunotherapy, chemotherapy and new combinations

  • short review

Colorectal cancer screening and prevention—pros and cons

  • Open Access
  • short review

Immunotherapeutic approach to a case of advanced hepatoid adenocarcinoma of the lung

  • Open Access
  • case report

HIV-triggered lymphoma

  • short review

Immunosuppression and its complications

  • editorial

Cure is not enough! Why it is time to act and close the gap

  • short review